pharma could see a wave of m&a activity in 2024, says jefferies' michael yee
Published 5 months ago • 4.8K plays • Length 3:34
Download video MP4
Download video MP3
Similar videos
-
5:58
we see big pharma going after smaller biotechs in 2024, says jefferies' michael yee
-
3:33
jefferies' michael yee still likes amgen in the biotech sector
-
3:20
jefferies' michael yee expects big opportunities for a.i. in the biotech sector
-
2:46
biotech will face challenges this year, says jefferies' michael yee
-
5:00
jefferies michael yee explains why he is bullish on biotech in 2022
-
12:08
soundhound ai, inc.'s market moves: stock analysis & price forecast for tuesday
-
29:16
4 wide-moat stocks to buy for the long-term while they’re undervalued today
-
2:35:20
keto-fm | esfna atlanta 2024
-
3:36
still a lot of uncertainty in moderna stock: jefferies' michael yee
-
4:09
$iova iovance biotherapeutics will provide financial guidance soon (2024q2 jefferies' michael yee)
-
5:17
fed should 'tee up' rate cuts next meeting, says wharton's jeremy siegel
-
4:59
we are expecting life sciences to be stronger in the second half of 2024, says merck kgaa ceo
-
4:31
jefferies' michael yee expects amgen's horizon therapeutics deal will go through despite ftc block
-
5:43
sarepta ceo on what's next after expanded muscular dystrophy drug approval
-
4:30
why health care could drive the next wave of ai growth
-
4:14
tech momentum to last through summer, expect seasonal weakness in fall, says bakeravenue's king lip
-
2:31
we still think there's more room for biotech to go higher, says jefferies' yee
-
1:07
stocks of the hour: telix pharmaceuticals, avita medical, ezz life science
-
1:51
ai ‘may be’ the catalyst for a new hardware replacement cycle: analyst
-
2:04
cramer’s stop trading: alnylam pharma
-
4:01
san francisco fed president mary daly: pce data shows us that monetary policy is working
-
2:57
jefferies' michael yee explains his top biotech picks: vrtx, fate, zlab
Clip.africa.com - Privacy-policy